Publicaciones en colaboración con investigadores/as de Academic Medical Center (30)

2024

  1. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

2023

  1. Automatic Segmentation of Retinal Layers in Multiple Neurodegenerative Disorder Scenarios

    IEEE Journal of Biomedical and Health Informatics, Vol. 27, Núm. 11, pp. 5483-5494

2022

  1. Commentary on “Voice Rehabilitation by Voice Prostheses After Total Laryngectomy: A Systematic Review and Network Meta-Analysis for 11,918 Patients”

    Journal of Speech, Language, and Hearing Research

  2. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the State of Genetic Testing for Cardiac Diseases

    Heart Rhythm, Vol. 19, Núm. 7, pp. e1-e60

  3. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Vol. 24, Núm. 8, pp. 1307-1367

  4. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases

    Journal of Arrhythmia, Vol. 38, Núm. 4, pp. 491-553

  5. Geoeconomic variations in epidemiology, ventilation management, and outcomes in invasively ventilated intensive care unit patients without acute respiratory distress syndrome: a pooled analysis of four observational studies

    The Lancet Global Health, Vol. 10, Núm. 2, pp. e227-e235

  6. It is time to define an organizational model for the prevention and management of infections along the surgical pathway: a worldwide cross-sectional survey

    World Journal of Emergency Surgery, Vol. 17, Núm. 1

  7. Real-world study of children and young adults with myeloproliferative neoplasms: identifying risks and unmet needs

    Blood Advances, Vol. 6, Núm. 17, pp. 5171-5183

2021

  1. A pandemic recap: lessons we have learned

    World Journal of Emergency Surgery

  2. Current use of cardiac magnetic resonance in tertiary referral centres for the diagnosis of cardiomyopathy: The ESC EORP Cardiomyopathy/Myocarditis Registry

    European Heart Journal Cardiovascular Imaging, Vol. 22, Núm. 7, pp. 781-789

  3. EEG measures for clinical research in major vascular cognitive impairment: recommendations by an expert panel

    Neurobiology of Aging, Vol. 103, pp. 78-97

  4. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2019

  1. Outcomes of Patients Presenting with Mild Acute Respiratory Distress Syndrome: Insights from the LUNG SAFE Study

    Anesthesiology, Vol. 130, Núm. 2, pp. 263-283

2018

  1. Immunocompromised patients with acute respiratory distress syndrome: Secondary analysis of the LUNG SAFE database

    Critical Care, Vol. 22, Núm. 1

  2. Research update for articles published in EJCI in 2016

    European Journal of Clinical Investigation, Vol. 48, Núm. 10

  3. Resolved versus confirmed ARDS after 24 h: insights from the LUNG SAFE study

    Intensive Care Medicine, Vol. 44, Núm. 5, pp. 564-577

  4. Risk factors for unfavourable postoperative outcome in patients with Crohn's disease undergoing right hemicolectomy or ileocaecal resection. An international audit by ESCP and S-ECCO

    Colorectal Disease, Vol. 20, Núm. 3, pp. 219-227

2017

  1. 2016 update of the EULAR recommendations for the management of early arthritis

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 6, pp. 948-959

2016

  1. Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study

    Journal of the American Heart Association, Vol. 5, Núm. 9